NISHA KOTECHA: Open Payments
NPI 1093144719 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 33 payments from 7 companies in 2025. Trend: 2023 $224 · 2024 $304 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $322 |
| ABBVIE INC. | 2 | $58 |
| Corcept Therapeutics | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NUCALA, TRELEGY ELLIPTA, VRAYLAR, Korlym, KRYSTEXXA, MOUNJARO, Wegovy, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
